See more : SBI Insurance Group Co., Ltd. (7326.T) Income Statement Analysis – Financial Results
Complete financial analysis of Ligua Inc. (7090.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ligua Inc., a leading company in the Healthcare industry within the Healthcare sector.
- RAMM Pharma Corp. (RAMM.CN) Income Statement Analysis – Financial Results
- Coolpad Group Limited (CHWTF) Income Statement Analysis – Financial Results
- Otsuka Holdings Co., Ltd. (OTSKF) Income Statement Analysis – Financial Results
- Propdo Ltd (PRPD.TA) Income Statement Analysis – Financial Results
- Incap Oyj (ICP1V.HE) Income Statement Analysis – Financial Results
Ligua Inc. (7090.T)
About Ligua Inc.
Ligua Inc., a consultancy company, engages in the provision of management support services in the healthcare industry. It operates through two segments: Orthopedic Clinic Solutions Business and Financial Services Business. The company offers orthopedic clinic software solutions comprising Ligoo POS & CRM, a patient information management system for osteopathic clinics; and ReceONE is a receipt calculation system used when submitting a medical expenses payment application to a health insurance association. It also provides orthopedic clinic equipment/consumables, such as EMS-indepth-, an electrical muscle stimulation device that exercises muscles by applying electrical stimulation to the body from the outside; Thomson bed, a hydraulic-electric treatment table, designed to treat pain caused by distortion of the pelvis and spine; Inject Energy, a low-frequency treatment device, used to reduce pain and improve muscle atrophy by stimulating the deep parts of the body; Dr.Supporter, a general medical device that uses Integrated Functional Mineral Crystal technology, that promotes blood circulation, recovers from fatigue, relieves muscle fatigue and stiffness, relieves neuralgia, lower back pain, muscle pain, and supports the core; and teaching materials and technical DVDs for treatment methods. In addition, the company educational training consulting services, including training programs and online customer attraction consulting based on the characteristics and guidelines of the orthopedic clinic industry; and medical expenses billing agency services. Further, it is involved in the insurance agency and financial instruments intermediary activities, as well as provision of financial consulting, including mergers and acquisitions mediation, to general business companies. The company was incorporated in 2004 and is headquartered in Osaka, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 3.43B | 2.84B | 3.20B | 2.69B | 2.17B |
Cost of Revenue | 1.55B | 1.61B | 1.57B | 1.25B | 935.00M |
Gross Profit | 1.88B | 1.22B | 1.63B | 1.44B | 1.23B |
Gross Profit Ratio | 54.79% | 43.16% | 51.04% | 53.65% | 56.85% |
Research & Development | 13.00M | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 240.00M | 222.00M | 173.00M | 171.00M | 148.00M |
Selling & Marketing | 1.52B | 1.51B | 1.30B | 1.02B | 860.00M |
SG&A | 1.75B | 1.73B | 1.48B | 1.19B | 1.01B |
Other Expenses | 0.00 | -2.57M | 2.77M | 2.44M | 0.00 |
Operating Expenses | 1.76B | 1.73B | 1.48B | 1.19B | 1.03B |
Cost & Expenses | 3.31B | 3.35B | 3.04B | 2.44B | 1.96B |
Interest Income | 75.00K | 10.00K | 13.00K | 43.00K | 60.00K |
Interest Expense | 21.09M | 16.53M | 10.07M | 9.81M | 2.75M |
Depreciation & Amortization | 156.58M | 249.61M | 200.97M | 86.42M | 81.00M |
EBITDA | 302.25M | -620.08M | 329.90M | 332.91M | 305.00M |
EBITDA Ratio | 8.81% | -9.20% | 11.31% | 12.50% | 14.07% |
Operating Income | 118.33M | -508.17M | 158.50M | 247.12M | 224.00M |
Operating Income Ratio | 3.45% | -17.91% | 4.95% | 9.19% | 10.34% |
Total Other Income/Expenses | 6.25M | -378.04M | -39.64M | -10.44M | -20.92M |
Income Before Tax | 124.58M | -886.21M | 118.86M | 236.68M | 202.00M |
Income Before Tax Ratio | 3.63% | -31.23% | 3.71% | 8.81% | 9.32% |
Income Tax Expense | 20.66M | -108.90M | 46.46M | 79.45M | 60.00M |
Net Income | 104.09M | -774.47M | 72.41M | 157.24M | 142.00M |
Net Income Ratio | 3.03% | -27.29% | 2.26% | 5.85% | 6.55% |
EPS | 71.23 | -552.13 | 51.64 | 116.50 | 138.24 |
EPS Diluted | 71.17 | -552.13 | 50.55 | 110.43 | 128.82 |
Weighted Avg Shares Out | 1.46M | 1.40M | 1.40M | 1.35M | 1.03M |
Weighted Avg Shares Out (Dil) | 1.46M | 1.40M | 1.43M | 1.42M | 1.10M |
Source: https://incomestatements.info
Category: Stock Reports